Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayaprakash Kotha

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Drug Development Research|February 4, 2014
The Utility of Platelet and Coagulation Testing of Antithrombotics: Fusing Science with Patient CareLisa K Jennings, Jayaprakash Kotha
Experimental Cell Research|March 25, 2008
Tetraspanin CD9 regulates beta 1 integrin activation and enhances cell motility to fibronectin via a PI-3 kinase-dependent pathwayJayaprakash Kotha, Celia Longhurst, Whitney Appling, et al.
Cardiovascular Research|March 3, 2009
Tetraspanins and vascular functionsFeng Zhang, Jayaprakash Kotha, Lisa K Jennings, et al.
Plos One|July 11, 2013
Tetraspanin CD9 promotes the invasive phenotype of human fibrosarcoma cells via upregulation of matrix metalloproteinase-9Michael J Herr, Jayaprakash Kotha, Nikolaus Hagedorn, et al.
Atherosclerosis|September 19, 2008
Functional relevance of tetraspanin CD9 in vascular smooth muscle cell injury phenotypes: a novel target for the prevention of neointimal hyperplasiaJayaprakash Kotha, Chunxiang Zhang, Celia M Longhurst, et al.
Bioanalysis|March 22, 2025
Enhancing clinical research with pharmacogenomics: a practical perspectiveXiaolong Tom Zhang, Jacob Blacutt, Thomas Lloyd, et al.
Biochemical and Biophysical Research Communications|April 22, 2014
Tetraspanin CD9 modulates human lymphoma cellular proliferation via histone deacetylase activityMichael J Herr, Celia M Longhurst, Benjamin Baker, et al.
Thrombosis Research|September 29, 2015
Platelet function recovery following exposure to triple anti-platelet inhibitors using an in vitro transfusion modelVinay Bhal, Michael J Herr, Mason Dixon, et al.
Platelets|April 23, 2014
PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intactHeather M Judge, Lisa K Jennings, David J Moliterno, et al.
Thrombosis and Haemostasis|January 10, 2014
Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic SubstudyRobert F Storey, Jayaprakash Kotha, Susan S Smyth, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Drug Development Research|February 4, 2014
The Utility of Platelet and Coagulation Testing of Antithrombotics: Fusing Science with Patient CareLisa K Jennings, Jayaprakash Kotha
Experimental Cell Research|March 25, 2008
Tetraspanin CD9 regulates beta 1 integrin activation and enhances cell motility to fibronectin via a PI-3 kinase-dependent pathwayJayaprakash Kotha, Celia Longhurst, Whitney Appling, et al.
Cardiovascular Research|March 3, 2009
Tetraspanins and vascular functionsFeng Zhang, Jayaprakash Kotha, Lisa K Jennings, et al.
Plos One|July 11, 2013
Tetraspanin CD9 promotes the invasive phenotype of human fibrosarcoma cells via upregulation of matrix metalloproteinase-9Michael J Herr, Jayaprakash Kotha, Nikolaus Hagedorn, et al.
Atherosclerosis|September 19, 2008
Functional relevance of tetraspanin CD9 in vascular smooth muscle cell injury phenotypes: a novel target for the prevention of neointimal hyperplasiaJayaprakash Kotha, Chunxiang Zhang, Celia M Longhurst, et al.
Bioanalysis|March 22, 2025
Enhancing clinical research with pharmacogenomics: a practical perspectiveXiaolong Tom Zhang, Jacob Blacutt, Thomas Lloyd, et al.
Biochemical and Biophysical Research Communications|April 22, 2014
Tetraspanin CD9 modulates human lymphoma cellular proliferation via histone deacetylase activityMichael J Herr, Celia M Longhurst, Benjamin Baker, et al.
Thrombosis Research|September 29, 2015
Platelet function recovery following exposure to triple anti-platelet inhibitors using an in vitro transfusion modelVinay Bhal, Michael J Herr, Mason Dixon, et al.
Platelets|April 23, 2014
PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intactHeather M Judge, Lisa K Jennings, David J Moliterno, et al.
Thrombosis and Haemostasis|January 10, 2014
Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic SubstudyRobert F Storey, Jayaprakash Kotha, Susan S Smyth, et al.
Pageof 1